Legal Representation
Attorney
William S. Fultz
USPTO Deadlines
Next Deadline
1834 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-07-30)
Due Date
July 30, 2030
Grace Period Ends
January 30, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
36 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Feb 8, 2025 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB | Loading... |
Jan 16, 2025 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB | Loading... |
Jan 16, 2025 | FIMP | P | FINAL DISPOSITION PROCESSED | Loading... |
Oct 30, 2024 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | Loading... |
Aug 9, 2024 | ADCH | M | CHANGE OF NAME/ADDRESS REC'D FROM IB | Loading... |
Jul 30, 2024 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
Jul 30, 2024 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
May 21, 2024 | GPNX | P | NOTIFICATION PROCESSED BY IB | Loading... |
May 14, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
May 14, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
May 1, 2024 | OP2R | P | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | Loading... |
May 1, 2024 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
Apr 24, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Apr 10, 2024 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
Apr 10, 2024 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
Apr 10, 2024 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
Apr 10, 2024 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
Apr 10, 2024 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Nov 12, 2023 | OPNX | P | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | Loading... |
Oct 25, 2023 | OPNR | P | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | Loading... |
Oct 25, 2023 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
Sep 27, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Sep 27, 2023 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
Sep 27, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Jul 3, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Jul 3, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Jul 3, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Apr 19, 2023 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
Mar 28, 2023 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
Mar 28, 2023 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
Feb 2, 2023 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
Feb 1, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Jan 30, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
May 27, 2022 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
May 23, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
May 19, 2022 | SDRC | M | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB | Loading... |
Detailed Classifications
Class 003
Cosmetics; cosmetic creams; oils for cosmetic purposes; lotions for cosmetic purposes; beauty masks; cosmetic preparations for skin care; cosmetic preparations made from hyaluronic acid; cosmetic preparations made from lidocaine; cosmetic preparations for filling wrinkles; age retardant gels; age retardant lotions; non-medicated anti-aging skin care preparations; anti-aging creams; anti-aging moisturizers
Class 005
Pharmaceutical preparations for use in dermatology; pharmaceutical preparations for filling wrinkles; injectable preparations for filling wrinkles for medical and pharmaceutical purposes; injectable preparations for medical and pharmaceutical purposes, namely, injectable dermal fillers; pharmaceutical preparations made from hyaluronic acid for use in dermatology; pharmaceutical preparations made from lidocaine for use in dermatology; injectable pharmaceutical preparations made from lidocaine for use as local anesthetics; injectable pharmaceutical preparations made from hyaluronic acid for use in dermatology; filled syringes sold filled with pharmaceutical preparations made from lidocaine and hyaluronic acid for medical purposes; pre-filled syringes sold filled with pharmaceutical preparations made from lidocaine and hyaluronic acid for medical purposes; medicinal creams for skin care; gels, creams and solutions for dermatological use; medicated lotions for skin care; medicated dermatological preparations
Additional Information
Design Mark
The mark consists of the stylized wording "DURAFORM" with a droplet design replacing the letter "O".
Classification
International Classes
003
005